Nitric Oxide is a Potential Diagnostic Marker for Hepatocellular Carcinoma
Open Access
- 1 January 2013
- journal article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 81 (3), 763-775
- https://doi.org/10.3797/scipharm.1307-09
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the seventh most common in women. This cancer varies widely in incidence throughout the world, with rising incidence in Egypt. HCC is considered the second most frequent cause of cancer incidence and mortality among men in Egypt. This study aimed to estimate the serum levels of nitric oxide (NO) and glutathione reductase in order to evaluate their role as oxidative status markers in HCC development and progression. For this purpose, serum levels of these parameters were assessed in 50 HCC patients, and 30 cirrhotic patients in addition to 15 healthy subjects as a control group. In the present study, glutathione reductase activity showed a significant increase in HCC as compared to the control group (P= 0.019). On the other hand, no significant difference was observed between the cirrhotic and HCC patients (P= 0.492). Serum NO was significantly higher in patients with HCC than in cirrhotic patients (P= 0.001) or the control group (P= 0.001), with a sensitivity of (74%) and specificity of (88.89%) at a cut-off level of 614.1 μmol/l. While AFP, alpha-fetoprotein, at a cutoff level of 200 ng/ml had a sensitivity of (52%), the specificity was (100%). Indeed, nitric oxide was high in 62.5% of AFP-negative HCC patients. In conclusion, glutathione reductase has no role in HCC diagnosis. However, nitric oxide is a potential diagnostic marker for HCC. The simultaneous determination of serum nitric oxide and AFP gave significant improvement in the detection of HCC patients compared to that of AFP alone.This publication has 31 references indexed in Scilit:
- Relevance of Serum Levels of Interleukin-6 and Syndecan-1 in Patients with Hepatocellular CarcinomaScientia Pharmaceutica, 2012
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2011
- Glutathione reductase plays an anti-apoptotic role against oxidative stress in human hepatoma cellsBiochimie, 2010
- Nodules Less Than 20 mm and Vascular Invasion are Predictors of Survival in Small Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2009
- Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta‐analysisInternational Journal of Cancer, 2008
- Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitisIndian Journal of Medical Microbiology, 2007
- Glutathione in Cancer Biology and TherapyCritical Reviews in Clinical Laboratory Sciences, 2006
- Essential Roles of S-Nitrosothiols in Vascular Homeostasis and Endotoxic ShockCell, 2004
- No-induced oxidative stress and glutathione metabolism in rodent and human cellsFree Radical Biology & Medicine, 1996
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973